Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

The Cell Cycle Control System01:28

The Cell Cycle Control System

2.4K
The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
2.4K
Cell Lines01:16

Cell Lines

7.1K
A cell line is a population of cells grown in vitro that can be subcultured over several generations. Normal cells cease to divide after a certain number of cell divisions, a process known as replicative senescence. This number, called the Hayflick limit, was conceptualized by Leonard Hayflick in 1961 when he observed that fetal cells grown in culture could only divide 40-60 times. This limit is due to the shortening of the telomeres during each round of cell division, preventing cell division...
7.1K
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

21.9K
Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
21.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

End to Side Microvascular Anastomosis in External Carotid Artery in Vessel Depleted Neck: A Case Series.

Journal of maxillofacial and oral surgery·2026
Same author

Two decades of advancing safe and effective cell-based therapies: a review of the impact, promise, and current limitations of USA regulation 21 CFR Part 1271.

Cytotherapy·2026
Same author

Knotless Suture for Primary Wound Closure Following Surgical Removal of Impacted Mandibular Third Molars - A Comparative Study.

Annals of maxillofacial surgery·2026
Same author

Role of Lipoprotein(a) in Atherosclerotic Cardiovascular Disease in South Asian Individuals.

Journal of the American Heart Association·2025
Same author

Evaluating the potential of Halomonas pacifica DJ6.1 L-asparaginase: statistical production optimization, biochemical characterization and anticancer attributes using Caco-2 cell lines.

International journal of biological macromolecules·2025
Same author

Treatment of non-Hodgkin lymphoma with point-of-care manufactured CAR T cells: a dual institution, phase 1 trial.

EClinicalMedicine·2025
Same journal

CAR-T cell therapy for multiple myeloma: An update on the current state and future potential.

Best practice & research. Clinical haematology·2025
Same journal

Cancer vaccines in hematologic malignancy: A systematic review of the rational and evidence for clinical use.

Best practice & research. Clinical haematology·2025
Same journal

Immune therapy of haematological cancers.

Best practice & research. Clinical haematology·2025
Same journal

Advances in NK cell therapy for multiple myeloma.

Best practice & research. Clinical haematology·2025
Same journal

Adoptive cellular therapies in multiple myeloma.

Best practice & research. Clinical haematology·2025
Same journal

Bispecific T-cell engager therapy for multiple myeloma.

Best practice & research. Clinical haematology·2025
查看所有相关文章

相关实验视频

Updated: May 10, 2025

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.2K

创建一个GMP细胞处理程序:专注于质量和监管.

Darshan Patel1, Jane Reese Koç2, Folashade Otegbeye3

  • 1Therapeutic Products Program, Fred Hutchinson Cancer Center, 1100 Fairview Ave. N, Seattle, WA, 98109, USA.

Best practice & research. Clinical haematology
|April 24, 2025
PubMed
概括
此摘要是机器生成的。

在早期细胞疗法研究中建立良好的制造实践 (GMP) 可以确保产品的安全性和质量. 本综述详细介绍了为学术环境创建一个质量管理计划,涵盖整个细胞治疗生命周期.

关键词:
细胞处理设施的细胞处理设施.良好的制造实践是指良好的制造实践.质量管理计划的质量管理程序.

更多相关视频

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells
06:47

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

Published on: October 6, 2023

404
Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers
09:44

Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers

Published on: July 7, 2023

3.0K

相关实验视频

Last Updated: May 10, 2025

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.2K
A GMP-Compliant Procedure for the Generation of Gene-Modified T cells
06:47

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

Published on: October 6, 2023

404
Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers
09:44

Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers

Published on: July 7, 2023

3.0K

科学领域:

  • 细胞和分子医学是细胞和分子医学.
  • 生物技术是生物技术.
  • 监管科学 监管科学

背景情况:

  • 实施良好的制造实践 (GMP) 对基于细胞的疗法的安全性和质量至关重要.
  • 学术研究项目需要指导,以建立符合GMP的细胞处理.

研究的目的:

  • 概述在学术环境中开发一个强大的符合GMP的细胞处理程序的全面步骤.
  • 为细胞治疗产品生命周期建立质量管理计划 (QMP) 提供指导.

主要方法:

  • 审查监管机构 (例如FDA,EMA) 的现行质量原则和指南.
  • 专注于在细胞疗法制造中遵守GMP的共同要求.
  • 为质量管理计划 (QMP) 制定框架.

主要成果:

  • 建立符合GMP的细胞处理程序的详细方法.
  • 在细胞疗法产品生命周期 (从采购到管理) 中识别关键因素.
  • 重点是合格的员工,明确的程序,设施/设备资格和材料控制.

结论:

  • 一个全面的质量管理计划对于确保细胞治疗的质量结果至关重要.
  • 持续的流程改进和趋势检测是GMP的关键组成部分.
  • 从早期阶段遵守良好生产规范原则对于安全和可再生的基于细胞的疗法至关重要.